RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: rheumatoid arthritis
Accession: DOID:7148
browse the term
Definition: An arthritis that is an autoimmune disease which attacks healthy cells and tissue located_in joint. (DO)
Synonyms: exact_synonym: RA; atrophic arthritis; rheumatic arthritis or polyarthritis
narrow_synonym: ACPA-negative rheumatoid arthritis; ACPA-positive rheumatoid arthritis; RHEUMATOID ARTHRITIS, PROGRESSION OF; SLC22A4-RELATED CONDITION
related_synonym: rheumatoid arthritis, susceptibility to
primary_id: MESH:D001172
alt_id: MIM:180300
xref: EFO:0000685 ; EFO:0009459 ; EFO:0009460 ; ICD10CM:M06.9 ; ICD9CM:714.0 ; NCI:C2884
For additional species annotation, visit the
Alliance of Genome Resources .
G
A2M
alpha-2-macroglobulin
IEA
GAD
PMID:15118671
RGD:1331525
NCBI chr12:9,067,708...9,116,229
Ensembl chr12:9,067,664...9,116,229
G
ABCB1
ATP binding cassette subfamily B member 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20080907 PMID:22104130
NCBI chr 7:87,503,017...87,713,295
Ensembl chr 7:87,503,017...87,713,323
G
ABCC2
ATP binding cassette subfamily C member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr10:99,782,640...99,852,594
Ensembl chr10:99,782,640...99,852,594
G
ABCC3
ATP binding cassette subfamily C member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr17:50,634,881...50,692,253
Ensembl chr17:50,634,777...50,692,253
G
ABCC4
ATP binding cassette subfamily C member 4 (PEL blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr13:95,019,835...95,301,451
Ensembl chr13:95,019,835...95,301,475
G
ABCC5
ATP binding cassette subfamily C member 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 3:183,919,934...184,017,884
Ensembl chr 3:183,919,934...184,017,939
G
ABCG2
ATP binding cassette subfamily G member 2 (JR blood group)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 4:88,090,264...88,231,626
Ensembl chr 4:88,090,150...88,231,628
G
ACAN
aggrecan
disease_progression
IEP EXP
protein:increased degradation:cartilage CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:15292528 PMID:16507130
RGD:11570537
NCBI chr15:88,803,436...88,875,353
Ensembl chr15:88,803,436...88,875,353
G
ACKR3
atypical chemokine receptor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 2:236,537,122...236,582,354
Ensembl chr 2:236,567,787...236,582,354
G
ADAMTS4
ADAM metallopeptidase with thrombospondin type 1 motif 4
IEP
mRNA:increased expression:synovium
RGD
PMID:11801682
RGD:10043106
NCBI chr 1:161,184,302...161,199,054
Ensembl chr 1:161,184,302...161,199,054
G
ADAMTS5
ADAM metallopeptidase with thrombospondin type 1 motif 5
IEP
protein:alternative form:synovium
RGD
PMID:11801682
RGD:10043106
NCBI chr21:26,917,922...26,967,088
Ensembl chr21:26,917,922...26,967,088
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
IEP EXP
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12833524 PMID:21789720
RGD:5686424
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
G
ADORA2A
adenosine A2a receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr22:24,423,597...24,442,357
Ensembl chr22:24,417,879...24,442,357
G
ADRB3
adrenoceptor beta 3
IAGP
DNA:missense mutation:cds:p.W64R rs4994 (human)
RGD
PMID:12739037
RGD:5684893
NCBI chr 8:37,962,990...37,966,599
Ensembl chr 8:37,962,990...37,966,599
G
AFF3
ALF transcription elongation factor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 2:99,545,419...100,142,590
Ensembl chr 2:99,545,419...100,192,428
G
AGER
advanced glycosylation end-product specific receptor
IEP EXP
protein:decreased expression:plasma (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16385501 PMID:20541603
RGD:7244141
NCBI chr 6:32,180,969...32,184,253
Ensembl chr 6:32,180,968...32,184,322
G
AHR
aryl hydrocarbon receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18617548
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
G
ALOX5
arachidonate 5-lipoxygenase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr10:45,374,216...45,446,117
Ensembl chr10:45,374,176...45,446,119
G
ANG
angiogenin
IEP
RGD
PMID:12653852
RGD:6892721
NCBI chr14:20,684,177...20,694,186
Ensembl chr14:20,684,177...20,698,971
G
ANKRD55
ankyrin repeat domain 55
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 5:56,099,680...56,233,330
Ensembl chr 5:56,099,680...56,233,330
G
ANXA3
annexin A3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr 4:78,551,770...78,610,447
Ensembl chr 4:78,551,747...78,610,451
G
AP4B1-AS1
AP4B1 antisense RNA 1
IAGP
ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO ClinVar Annotator: match by term: Rheumatoid arthritis
ClinVar
PMID:15004560 PMID:15208781 PMID:15273934 PMID:15580548 PMID:15719322 PMID:15744042 PMID:16273109 PMID:16339849 PMID:16470599 PMID:17170052 PMID:17436241 PMID:17554300 PMID:17878369 PMID:18301444 PMID:18978792 PMID:19265110 PMID:19430480 PMID:19898480 PMID:21841778 PMID:25741868 PMID:28492532 More...
NCBI chr 1:113,812,612...113,901,237
Ensembl chr 1:113,812,379...113,901,237
G
APOA4
apolipoprotein A4
IEP
protein:increased expression:blood serum (human)
RGD
PMID:20367977
RGD:5685646
NCBI chr11:116,820,700...116,823,304
Ensembl chr11:116,820,700...116,823,304
G
ARID5B
AT-rich interaction domain 5B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963 PMID:23143596
NCBI chr10:61,901,699...62,096,944
Ensembl chr10:61,901,684...62,096,944
G
ATIC
5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19193698
NCBI chr 2:215,312,059...215,368,592
Ensembl chr 2:215,311,956...215,349,773
G
AZGP1
alpha-2-glycoprotein 1, zinc-binding
ISO
mRNA:decreased expression:liver
RGD
PMID:18372237
RGD:153352318
NCBI chr 7:99,966,730...99,976,031
Ensembl chr 7:99,966,720...99,976,042
G
B3GNT2
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr 2:62,196,115...62,224,731
Ensembl chr 2:62,196,115...62,224,731
G
B3GNT9
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr16:67,148,104...67,150,998
Ensembl chr16:67,148,104...67,150,998
G
BAIAP2L1
BAR/IMD domain containing adaptor protein 2 like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 7:98,291,650...98,401,090
Ensembl chr 7:98,291,650...98,401,090
G
BCL2A1
BCL2 related protein A1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr15:79,960,892...79,971,196
Ensembl chr15:79,960,892...79,971,196
G
BDKRB2
bradykinin receptor B2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr14:96,204,839...96,244,164
Ensembl chr14:96,204,679...96,244,166
G
BGLAP
bone gamma-carboxyglutamate protein
IDA IEP
protein:increased expression:serum
RGD
PMID:22447331 PMID:3488088
RGD:6483593 , RGD:6483600
NCBI chr 1:156,242,184...156,243,317
Ensembl chr 1:156,242,184...156,243,317
G
BGN
biglycan
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr X:153,494,980...153,509,546
Ensembl chr X:153,494,980...153,509,546
G
BLK
BLK proto-oncogene, Src family tyrosine kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 8:11,494,387...11,564,599
Ensembl chr 8:11,486,894...11,564,599
G
BMP4
bone morphogenetic protein 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr14:53,949,736...53,956,891
Ensembl chr14:53,949,736...53,958,761
G
BMP6
bone morphogenetic protein 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr 6:7,726,099...7,881,728
Ensembl chr 6:7,726,099...7,881,728
G
BTNL2
butyrophilin like 2
susceptibility
IAGP
DNA:SNPs: :
RGD
PMID:23364395
RGD:9685033
NCBI chr 6:32,393,339...32,407,181
Ensembl chr 6:32,393,339...32,407,181
G
C3
complement C3
IEP
RGD
PMID:7561187
RGD:11040775
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
C4B
complement C4B (Chido/Rodgers blood group)
IAGP
RGD
PMID:22076784
RGD:5688263
NCBI chr 6:32,014,795...32,035,418
Ensembl chr 6:32,014,795...32,035,418
G
CA1
carbonic anhydrase 1
IDA
RGD
PMID:12806141
RGD:408425977
NCBI chr 8:85,327,608...85,378,113
Ensembl chr 8:85,327,608...85,379,014
G
CA2
carbonic anhydrase 2
IDA
RGD
PMID:12806141
RGD:408425977
NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493
G
CALD1
caldesmon 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr 7:134,745,467...134,970,729
Ensembl chr 7:134,744,252...134,970,729
G
CASP7
caspase 7
IEP
RGD
PMID:18785314
RGD:5684540
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
G
CAST
calpastatin
IDA
RGD
PMID:7706496
RGD:5683620
NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,247,756...96,779,595 Ensembl chr 5:96,247,756...96,779,595
G
CAT
catalase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CAV2
caveolin 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 7:116,499,738...116,508,541
Ensembl chr 7:116,287,380...116,508,541
G
CCL2
C-C motif chemokine ligand 2
IEP
protein:increased expression:serum
RGD
PMID:20056091
RGD:4891442
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,274...34,257,208
G
CCL21
C-C motif chemokine ligand 21
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853 PMID:20453842 PMID:23143596
NCBI chr 9:34,709,005...34,710,136
Ensembl chr 9:34,709,005...34,710,136
G
CCL22
C-C motif chemokine ligand 22
IEP
protein:increased expression:plasma:
RGD
PMID:19942450
RGD:10054497
NCBI chr16:57,357,909...57,366,189
Ensembl chr16:57,358,783...57,366,189
G
CCL8
C-C motif chemokine ligand 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr17:34,319,435...34,321,402
Ensembl chr17:34,319,435...34,321,402
G
CCN1
cellular communication network factor 1
EXP IEP
CTD Direct Evidence: marker/mechanism protein:increased expression:blood serum (human)
CTD RGD
PMID:19192274 PMID:34031328
RGD:329845561
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
G
CCN2
cellular communication network factor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 6:131,948,176...131,951,372
Ensembl chr 6:131,948,176...131,951,372
G
CCR1
C-C motif chemokine receptor 1
IMP
RGD
PMID:12860725
RGD:5688170
NCBI chr 3:46,201,711...46,208,313
Ensembl chr 3:46,201,711...46,208,313
G
CCR3
C-C motif chemokine receptor 3
IEP
protein:increased expression:synovial fluid, neutrophil
RGD
PMID:19017998
RGD:4145632
NCBI chr 3:46,210,696...46,266,706
Ensembl chr 3:46,130,890...46,266,706
G
CCR4
C-C motif chemokine receptor 4
IEP
protein:increased expression:synovial membrane: mRNA:increased expression:synovium:
RGD
PMID:19942450 PMID:25430645
RGD:10054497 , RGD:10054499
NCBI chr 3:32,951,644...32,956,349
Ensembl chr 3:32,951,644...32,957,120
G
CCR5
C-C motif chemokine receptor 5
resistance no_association
IAGP
DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:16541097 PMID:17565662
RGD:1626290 , RGD:1626283
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CCR6
C-C motif chemokine receptor 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453841 PMID:20453842 PMID:23143596
NCBI chr 6:167,111,795...167,139,141
Ensembl chr 6:167,111,807...167,139,141
G
CD2
CD2 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 1:116,754,430...116,769,229
Ensembl chr 1:116,754,430...116,769,229
G
CD244
CD244 molecule
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Rheumatoid arthritis CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:18794858
NCBI chr 1:160,830,160...160,862,887
Ensembl chr 1:160,830,160...160,862,887
G
CD28
CD28 molecule
IEP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19898481 PMID:20453842 PMID:23143596 PMID:19075187
RGD:5131619
NCBI chr 2:203,706,482...203,738,912
Ensembl chr 2:203,706,517...203,739,756
G
CD3E
CD3 epsilon subunit of T-cell receptor complex
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr11:118,304,730...118,316,173
Ensembl chr11:118,304,730...118,316,175
G
CD40
CD40 molecule
IAGP EXP
DNA:SNP: :rs4810485 (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:18794853 PMID:20453842 PMID:23143596 PMID:20498205
RGD:5490972
NCBI chr20:46,118,314...46,129,858
Ensembl chr20:46,118,271...46,129,863
G
CD5
CD5 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr11:61,093,963...61,127,852
Ensembl chr11:61,102,489...61,127,852
G
CD80
CD80 molecule
IEP
protein:increased expression:serum
RGD
PMID:22917707
RGD:6893647
NCBI chr 3:119,524,293...119,559,614
Ensembl chr 3:119,524,293...119,559,614
G
CD83
CD83 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,140,682
G
CDK6
cyclin dependent kinase 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853
NCBI chr 7:92,604,921...92,836,573
Ensembl chr 7:92,604,921...92,836,573
G
CEBPB
CCAAT enhancer binding protein beta
IEP
protein:increased expression:knee, articular cartilage (human)
RGD
PMID:19248099
RGD:10401213
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,734...50,192,690
G
CHI3L1
chitinase 3 like 1
severity
IEP
protein:increased secretion:serum (human)
RGD
PMID:10461474
RGD:4892605
NCBI chr 1:203,178,931...203,186,704
Ensembl chr 1:203,178,931...203,186,704
G
CHRNA7
cholinergic receptor nicotinic alpha 7 subunit
ISO
mRNA,protein:increased expression:joint, spleen:
RGD
PMID:31279484
RGD:151676715
NCBI chr15:32,030,483...32,173,018
Ensembl chr15:31,923,438...32,173,018
G
CHRNG
cholinergic receptor nicotinic gamma subunit
IAGP
ClinVar Annotator: match by term: Rheumatoid arthritis
ClinVar
PMID:23261301 PMID:25741868 PMID:28492532
NCBI chr 2:232,539,692...232,548,115
Ensembl chr 2:232,539,692...232,548,115
G
CIITA
class II major histocompatibility complex transactivator
susceptibility no_association
IAGP EXP
DNA:haplotype:promoter/CDS:rs3087456G/rs4774C ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO | ClinVar Annotator: match by term: Rheumatoid arthritis CTD Direct Evidence: marker/mechanism DNA:polymorphism:promoter:-168A>G DNA:polymorphism:promoter:rs3087456, no association in a German cohort
OMIM ClinVar CTD RGD
PMID:15821736 PMID:16849401 PMID:25741868 PMID:28492532 PMID:19221398 PMID:15821736 PMID:16426246 More...
RGD:5491176 , RGD:1358146 , RGD:5491189
NCBI chr16:10,866,206...10,943,021
Ensembl chr16:10,866,222...10,943,021
G
CLEC12A
C-type lectin domain family 12 member A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr12:9,951,268...10,006,150
Ensembl chr12:9,951,316...9,995,694
G
CLEC16A
C-type lectin domain containing 16A
IAGP
DNA:polymorphism:intron:rs6498169G
RGD
PMID:19221398
RGD:5491176
NCBI chr16:10,944,564...11,182,186
Ensembl chr16:10,944,539...11,182,186
G
COL2A1
collagen type II alpha 1 chain
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:27028940 PMID:29935983
NCBI chr12:47,972,967...48,006,212
Ensembl chr12:47,972,967...48,004,554
G
CP
ceruloplasmin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26001728
NCBI chr 3:149,162,414...149,221,829
Ensembl chr 3:149,162,410...149,221,829
G
CRP
C-reactive protein
IEP EXP ISO
protein:increased expression:serum CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:1568518 PMID:22173958 PMID:22173958
RGD:6904209 , RGD:6904209
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CSF2
colony stimulating factor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr 5:132,073,789...132,076,170
Ensembl chr 5:132,073,789...132,076,170
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CTSD
cathepsin D
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr11:1,752,755...1,763,927
Ensembl chr11:1,752,752...1,764,573
G
CX3CL1
C-X3-C motif chemokine ligand 1
IEP
RGD
PMID:11465708
RGD:4892002
NCBI chr16:57,372,490...57,385,044
Ensembl chr16:57,372,477...57,385,044
G
CXCL2
C-X-C motif chemokine ligand 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr 4:74,097,040...74,099,195
Ensembl chr 4:74,097,040...74,099,196
G
CXCL6
C-X-C motif chemokine ligand 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528
NCBI chr 4:73,836,678...73,838,760
Ensembl chr 4:73,836,640...73,849,064
G
CXCL8
C-X-C motif chemokine ligand 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860 PMID:19192274
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CXCR3
C-X-C motif chemokine receptor 3
IEP
protein:increased expression:synovial fluid, neutrophil
RGD
PMID:19017998
RGD:4145632
NCBI chr X:71,615,919...71,618,511
Ensembl chr X:71,615,916...71,618,511
G
CXCR4
C-X-C motif chemokine receptor 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
CYBB
cytochrome b-245 beta chain
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24313545
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,018...37,813,461
G
DDIT4
DNA damage inducible transcript 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr10:72,273,924...72,276,036
Ensembl chr10:72,273,919...72,276,036
G
DDX6
DEAD-box helicase 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr11:118,747,763...118,791,744
Ensembl chr11:118,747,763...118,791,164
G
DHFR
dihydrofolate reductase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 5:80,626,226...80,654,983
Ensembl chr 5:80,626,226...80,654,983
G
DNASE1L3
deoxyribonuclease 1L3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596 PMID:30224649
NCBI chr 3:58,192,257...58,210,972
Ensembl chr 3:58,192,257...58,214,697
G
DNASE2
deoxyribonuclease 2, lysosomal
ISS
OMIM:180300
MouseDO
NCBI chr19:12,875,209...12,881,449
Ensembl chr19:12,875,209...12,881,595
G
DNMT1
DNA methyltransferase 1
severity
IEP
mRNA:increased expression:mononuclear cell
RGD
PMID:20937307
RGD:9588623
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
G
DNMT3B
DNA methyltransferase 3 beta
disease_progression
IAGP
DNA:polymorphism:promoter:-283C>T(human)
RGD
PMID:19777235
RGD:9589110
NCBI chr20:32,762,385...32,809,356
Ensembl chr20:32,762,385...32,809,359
G
EDN1
endothelin 1
treatment
IDA
RGD
PMID:22249931
RGD:8661695
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
ELN
elastin
IDA
RGD
PMID:12643515
RGD:9585739
NCBI chr 7:74,028,173...74,069,907
Ensembl chr 7:74,027,789...74,069,907
G
ENO1
enolase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19898480
NCBI chr 1:8,861,000...8,878,686
Ensembl chr 1:8,861,000...8,879,190
G
EPAS1
endothelial PAS domain protein 1
IEP
protein:increased expression:layer of synovial tissue, stromal cell
RGD
PMID:12823854
RGD:10395366
NCBI chr 2:46,297,407...46,386,697
Ensembl chr 2:46,293,667...46,386,697
G
ESCO2
establishment of sister chromatid cohesion N-acetyltransferase 2
IEP
mRNA:increased expression:peripheral blood mononuclear cell
RGD
PMID:36104638
RGD:155791669
NCBI chr 8:27,771,974...27,819,660
Ensembl chr 8:27,771,949...27,812,640
G
ESR2
estrogen receptor 2
severity
IAGP
DNA:SNP:exon:rs1256049(human)
RGD
PMID:21523342
RGD:5508794
NCBI chr14:64,226,707...64,338,613
Ensembl chr14:64,084,232...64,338,112
G
F2
coagulation factor II, thrombin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:26001728
NCBI chr11:46,719,213...46,739,506
Ensembl chr11:46,719,196...46,739,506
G
FAS
Fas cell surface death receptor
susceptibility
IAGP IMP IEP
DNA:snp:promoter:g.-670A>G (human) protein:increased expression:serum (human)
RGD
PMID:23053964 PMID:20875116 PMID:12148596
RGD:8662433 , RGD:12903969 , RGD:8662455
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FASLG
Fas ligand
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr 1:172,659,103...172,666,876
Ensembl chr 1:172,659,103...172,666,876
G
FCGR1A
Fc gamma receptor Ia
IEP
protein:increased expression:synovial joint:
RGD
PMID:16670289
RGD:9685708
NCBI chr 1:149,782,694...149,800,609
Ensembl chr 1:149,782,671...149,791,675
G
FCGR2A
Fc gamma receptor IIa
IAGP EXP IDA
DNA:polymorphism: :p.H131R (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:20453842 PMID:23143596 PMID:12508778 PMID:8254199
RGD:5147978 , RGD:5147984
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
FCGR3A
Fc gamma receptor IIIa
susceptibility
IAGP IEP
DNA:polymorphism:exon:p.F158V(rs396991)(human) DNA:CNVs protein:decreased expression:NK cell
RGD
PMID:19019892 PMID:25154742 PMID:15334114
RGD:5508391 , RGD:11344974 , RGD:5508467
NCBI chr 1:161,541,759...161,550,737
Ensembl chr 1:161,541,759...161,550,968
G
FKBP5
FKBP prolyl isomerase 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 6:35,573,590...35,728,583
Ensembl chr 6:35,573,585...35,728,583
G
FOXO3
forkhead box O3
IEP
mRNA,protein:increased expression:peripheral blood mononuclear cell, polymorphonuclear cell,synovium:
RGD
PMID:19435720
RGD:10402186
NCBI chr 6:108,559,825...108,684,774
Ensembl chr 6:108,559,835...108,684,774
G
FOXP3
forkhead box P3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20476861
NCBI chr X:49,250,438...49,264,710
Ensembl chr X:49,250,438...49,264,800
G
FPGS
folylpolyglutamate synthase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 9:127,802,858...127,814,506
Ensembl chr 9:127,794,597...127,814,494
G
GART
phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr21:33,503,931...33,542,893
Ensembl chr21:33,503,931...33,543,491
G
GATA3
GATA binding protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr10:8,045,333...8,075,198
Ensembl chr10:8,045,378...8,075,198
G
GC
GC vitamin D binding protein
IEP EXP
protein:decreased expression:plasma CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:3874814 PMID:9548303
RGD:5509931
NCBI chr 4:71,741,693...71,805,520
Ensembl chr 4:71,741,696...71,804,041
G
GDF5
growth differentiation factor 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18830904
NCBI chr20:35,433,347...35,454,749
Ensembl chr20:35,433,347...35,454,746
G
GGH
gamma-glutamyl hydrolase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23897011
NCBI chr 8:63,015,079...63,038,806
Ensembl chr 8:63,014,881...63,039,407
G
GIN1
gypsy retrotransposon integrase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 5:103,086,000...103,120,138
Ensembl chr 5:103,086,000...103,120,138
G
GPRC5A
G protein-coupled receptor class C group 5 member A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr12:12,891,562...12,917,937
Ensembl chr12:12,890,782...12,917,937
G
GRK2
G protein-coupled receptor kinase 2
ISO EXP IEP
DNA: deletion: : heterozygous CTD Direct Evidence: marker/mechanism protein: decreased expression: mononuclear leukocytes
CTD RGD
PMID:10094932 PMID:18662895 PMID:10094932
RGD:5688373 , RGD:5688380
NCBI chr11:67,266,473...67,286,556
Ensembl chr11:67,266,473...67,286,556
G
GRK5
G protein-coupled receptor kinase 5
no_association
ISO IEP
DNA: deletion::GRK2 and GRK6 deletions resulted in more severe arthritis protein: : mononuclear blood cells
RGD
PMID:18662895 PMID:10094932
RGD:5688373 , RGD:5688380
NCBI chr10:119,207,571...119,459,745
Ensembl chr10:119,207,571...119,459,745
G
GRK6
G protein-coupled receptor kinase 6
ISO EXP IEP
DNA: deletion: : homozygous CTD Direct Evidence: marker/mechanism protein: decreased expression: mononuclear leukocytes
CTD RGD
PMID:10094932 PMID:18662895 PMID:10094932
RGD:5688373 , RGD:5688380
NCBI chr 5:177,425,523...177,442,891
Ensembl chr 5:177,403,204...177,442,901
G
GSDME
gasdermin E
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 7:24,698,355...24,795,539
Ensembl chr 7:24,698,355...24,757,940
G
GSTM1
glutathione S-transferase mu 1
susceptibility
IAGP
DNA:deletion: : DNA:deletion: :
RGD
PMID:16887863 PMID:15940757 PMID:16870093
RGD:5490993 , RGD:5490998 , RGD:5490994
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
GSTT1
glutathione S-transferase theta 1
severity susceptibility
IAGP
DNA:deletion: :
RGD
PMID:19473562 PMID:20401725 PMID:20597111
RGD:5490553 , RGD:5490983 , RGD:5490982
G
HAPLN1
hyaluronan and proteoglycan link protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 5:83,637,805...83,720,855
Ensembl chr 5:83,637,805...83,720,855
G
HCLS1
hematopoietic cell-specific Lyn substrate 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 3:121,631,399...121,660,903
Ensembl chr 3:121,631,399...121,660,927
G
HDAC1
histone deacetylase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:32289289
NCBI chr 1:32,292,083...32,333,626
Ensembl chr 1:32,292,083...32,333,635
G
HFE
homeostatic iron regulator
IAGP
DNA:missense mutation: :p.C282Y (rs1800562) (human)
RGD
PMID:30651232
RGD:14746965
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,226...26,098,343
G
HGF
hepatocyte growth factor
disease_progression
IEP
protein:increased expression:serum:
RGD
PMID:24387171
RGD:8548659
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
HIF1A
hypoxia inducible factor 1 subunit alpha
IEP
protein:increased expression:layer of synovial tissue, stromal cell
RGD
PMID:12823854
RGD:10395366
NCBI chr14:61,695,513...61,748,258
Ensembl chr14:61,695,513...61,748,259
G
HLA-DPB1
major histocompatibility complex, class II, DP beta 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17956852 PMID:22286218
NCBI chr 6:33,075,990...33,089,696
Ensembl chr 6:33,075,936...33,089,696
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
IAGP
DNA:polymorphisms (human) DNA:polymorphism (human)
RGD
PMID:11482129 PMID:11454644
RGD:5147859 , RGD:5147860
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQA2
major histocompatibility complex, class II, DQ alpha 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 6:32,741,391...32,747,198
Ensembl chr 6:32,741,391...32,747,198
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
IAGP
DNA:polymorphism (human)
RGD
PMID:11454644
RGD:5147860
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism DNA:polymorphism (human) DNA:polymorphisms (human) DNA:polymorphisms: :multiple (human)
CTD RGD
PMID:19898480 PMID:20453842 PMID:22286218 PMID:18512783 PMID:11454644 PMID:19117368 PMID:21246357 More...
RGD:4144826 , RGD:5147860 , RGD:5147616 , RGD:5147567
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HNRNPA2B1
heterogeneous nuclear ribonucleoprotein A2/B1
severity
ISO
RGD
PMID:18025202
RGD:9685481
NCBI chr 7:26,189,927...26,200,746
Ensembl chr 7:26,171,151...26,201,529
G
HOXD10
homeobox D10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 2:176,116,778...176,119,937
Ensembl chr 2:176,108,790...176,119,937
G
HOXD11
homeobox D11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 2:176,107,280...176,115,679
Ensembl chr 2:176,104,216...176,109,754
G
HOXD13
homeobox D13
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 2:176,087,487...176,095,944
Ensembl chr 2:176,092,721...176,095,944
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949
G
HSP90AA1
heat shock protein 90 alpha family class A member 1
IEP
mRNA:increased expression:peripheral blood leukocyte:
RGD
PMID:21417552
RGD:10402843
NCBI chr14:102,080,742...102,139,749
Ensembl chr14:102,080,742...102,139,699
G
HSPA4
heat shock protein family A (Hsp70) member 4
IEP
protein:increased expression:peripheral blood lymphocyte (human)
RGD
PMID:22047640
RGD:5688784
NCBI chr 5:133,052,013...133,106,449
Ensembl chr 5:133,052,013...133,106,449
G
HSPA5
heat shock protein family A (Hsp70) member 5
IEP
protein:increased expression:synovial joint
RGD
PMID:11315915
RGD:5685639
NCBI chr 9:125,234,853...125,241,343
Ensembl chr 9:125,234,853...125,241,382
G
HSPA9
heat shock protein family A (Hsp70) member 9
IEP
protein:increased expression:synovial cell:
RGD
PMID:23739258
RGD:10402561
NCBI chr 5:138,553,756...138,575,401
Ensembl chr 5:138,553,756...138,575,675
G
HSPB1
heat shock protein family B (small) member 1
IEP
protein:increased expression:serum:
RGD
PMID:21417552
RGD:10402843
NCBI chr 7:76,302,673...76,304,292
Ensembl chr 7:76,302,673...76,305,813
G
HSPD1
heat shock protein family D (Hsp60) member 1
IEP
mRNA:increased expression:peripheral blood leukocyte:
RGD
PMID:21417552
RGD:10402843
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
IFNG
interferon gamma
treatment
IDA IEP EXP
mRNA:increased expression:synovial (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22450443 PMID:1417133 PMID:22660635
RGD:8157623 , RGD:155663483
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IGF2
insulin like growth factor 2
IAGP IEP
DNA:loss of imprinting:synovial cell protein:decreased expression:plasma
RGD
PMID:19556211 PMID:11247331
RGD:5510001 , RGD:5510014
NCBI chr11:2,129,117...2,149,566
Ensembl chr11:2,129,112...2,158,391
G
IGFBP3
insulin like growth factor binding protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 7:45,912,245...45,921,272
Ensembl chr 7:45,912,245...45,921,874
G
IKZF3
IKAROS family zinc finger 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr17:39,757,715...39,864,312
Ensembl chr17:39,757,715...39,864,312
G
IL10
interleukin 10
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Rheumatoid arthritis, progression of ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO CTD Direct Evidence: marker/mechanism
ClinVar OMIM CTD
PMID:12847677 PMID:22450443 PMID:25741868 PMID:28492532
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL13
interleukin 13
IEP
protein:increased expression:serum
RGD
PMID:12051401
RGD:8549582
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL17A
interleukin 17A
treatment
IMP IEP
mRNA:increased expression:synovial (human)
RGD
PMID:20926833 PMID:22660635
RGD:9068415 , RGD:155663483
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16368150
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
G
IL19
interleukin 19
IAGP
ClinVar Annotator: match by term: Rheumatoid arthritis, progression of ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ClinVar
PMID:12847677 PMID:25741868 PMID:28492532
NCBI chr 1:206,770,773...206,842,981
Ensembl chr 1:206,770,764...206,842,981
G
IL1A
interleukin 1 alpha
severity
IDA IEP
associated with lung disease, interstitial protein:increased expression:plasma, synovial fluid
RGD
PMID:11192540 PMID:8162643
RGD:4142818 , RGD:7794716
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1B
interleukin 1 beta
IEP EXP
protein:decreased expression:serum mRNA:increased expression:synovial (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:12566094 PMID:17379860 PMID:22450443 PMID:22414257 PMID:22660635
RGD:6482656 , RGD:155663483
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IL1RN
interleukin 1 receptor antagonist
IDA EXP ISO
CTD Direct Evidence: marker/mechanism|therapeutic
CTD RGD
PMID:7706905 PMID:19192274 PMID:19447938 PMID:10637275
RGD:7174696 , RGD:8549810
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2
interleukin 2
IDA
RGD
PMID:6421522
RGD:8662948
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL20
interleukin 20
IEP
RGD
PMID:16947773
RGD:5147395
NCBI chr 1:206,863,565...206,869,223
Ensembl chr 1:206,865,623...206,869,223
G
IL21R
interleukin 21 receptor
ISO
RGD
PMID:19342640
RGD:6892964
NCBI chr16:27,402,174...27,452,042
Ensembl chr16:27,402,174...27,452,042
G
IL23A
interleukin 23 subunit alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr12:56,338,884...56,340,410
Ensembl chr12:56,334,174...56,340,410
G
IL23R
interleukin 23 receptor
susceptibility
IAGP
DNA:SNP::rs1343151(human)
RGD
PMID:18647855
RGD:8549596
NCBI chr 1:67,138,637...67,265,903
Ensembl chr 1:67,138,907...67,259,979
G
IL2RA
interleukin 2 receptor subunit alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:20476861 PMID:23143596
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
G
IL2RB
interleukin 2 receptor subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr22:37,125,838...37,175,118
Ensembl chr22:37,118,666...37,175,118
G
IL3
interleukin 3
IAGP
DNA: SNPs: Multiple: gene-gene interaction
RGD
PMID:20018070
RGD:5686905
NCBI chr 5:132,060,655...132,063,204
Ensembl chr 5:132,060,655...132,063,204
G
IL4R
interleukin 4 receptor
severity
IAGP
DNA:SNP: :rs1805010 (human)
RGD
PMID:24782180
RGD:10402783
NCBI chr16:27,313,756...27,364,778
Ensembl chr16:27,313,668...27,364,778
G
IL5
interleukin 5
IEP
RGD
PMID:22293286
RGD:5687156
NCBI chr 5:132,541,445...132,556,815
Ensembl chr 5:132,541,445...132,556,838
G
IL6
interleukin 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274 PMID:22450443
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6R
interleukin 6 receptor
EXP
CTD Direct Evidence: marker/mechanism|therapeutic
CTD
PMID:16729287 PMID:23143596
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
IL6ST
interleukin 6 cytokine family signal transducer
EXP ISS
CTD Direct Evidence: marker/mechanism OMIM:180300
CTD MouseDO
PMID:20453842
NCBI chr 5:55,935,095...55,994,963
Ensembl chr 5:55,935,095...55,995,022
G
IRAK1
interleukin 1 receptor associated kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr X:154,010,507...154,019,902
Ensembl chr X:154,010,506...154,019,902
G
IRF5
interferon regulatory factor 5
IAGP IDA EXP
ClinVar Annotator: match by term: Rheumatoid arthritis CTD Direct Evidence: marker/mechanism
ClinVar CTD RGD
PMID:15657875 PMID:16642019 PMID:17599733 PMID:18063667 PMID:20453842 PMID:23143596 PMID:29379122 PMID:29352853 More...
RGD:40924627 , RGD:40924559
NCBI chr 7:128,937,032...128,950,038
Ensembl chr 7:128,937,457...128,950,038
G
IRF8
interferon regulatory factor 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr16:85,899,162...85,922,609
Ensembl chr16:85,899,116...85,922,606
G
ITGA6
integrin subunit alpha 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 2:172,427,336...172,506,459
Ensembl chr 2:172,234,216...172,506,459
G
ITPA
inosine triphosphatase
treatment
IAGP
DNA:SNP: :94C>A(human)
RGD
PMID:29441893
RGD:14975307
NCBI chr20:3,204,065...3,227,449
Ensembl chr20:3,208,868...3,223,870
G
JAK2
Janus kinase 2
ISO
RGD
PMID:21510883
RGD:6483024
NCBI chr 9:4,984,390...5,129,948
Ensembl chr 9:4,984,390...5,129,948
G
KAT2B
lysine acetyltransferase 2B
IEP
mRNA:increased expression:peripheral blood mononuclear cell
RGD
PMID:36104638
RGD:155791669
NCBI chr 3:20,040,446...20,154,404
Ensembl chr 3:20,040,446...20,154,404
G
KIF5A
kinesin family member 5A
susceptibility
IAGP EXP
DNA:snp:intron:c.1717-152C>G (rs1678542) (human) CTD Direct Evidence: marker/mechanism DNA:snps:intron, 3' utr:c.2756-43A>C, c.*776C>T (rs775246, rs775251) (human)
CTD RGD
PMID:23143596 PMID:23378462 PMID:21784728
RGD:12793072 , RGD:12793073
NCBI chr12:57,550,044...57,586,633
Ensembl chr12:57,546,026...57,586,633
G
KMT2C
lysine methyltransferase 2C
treatment
ISO
RGD
PMID:33914205
RGD:151356764
NCBI chr 7:152,134,925...152,436,003
Ensembl chr 7:152,134,922...152,436,644
G
LCN2
lipocalin 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:7554268
NCBI chr 9:128,149,453...128,153,453
Ensembl chr 9:128,149,071...128,153,453
G
LHX2
LIM homeobox 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 9:124,011,768...124,033,301
Ensembl chr 9:124,001,670...124,033,301
G
LOC128462409
CRISPRi-FlowFISH-validated IL10 regulatory element GRCh37_chr1:206945468-206946089
IAGP
ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO
ClinVar
PMID:25741868 PMID:28492532
NCBI chr 1:206,772,123...206,772,744
G
LPA
lipoprotein(a)
IEP
protein:increased expression:serum
RGD
PMID:21523363
RGD:5509910
NCBI chr 6:160,531,482...160,664,275
Ensembl chr 6:160,531,482...160,664,275
G
LRRK2
leucine rich repeat kinase 2
IEP
RGD
PMID:17082220
RGD:5508419
NCBI chr12:40,224,997...40,369,285
Ensembl chr12:40,196,744...40,369,285
G
LY96
lymphocyte antigen 96
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr 8:73,991,392...74,099,857
Ensembl chr 8:73,991,392...74,029,079
G
MAB21L2
mab-21 like 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 4:150,582,151...150,584,693
Ensembl chr 4:150,582,151...150,584,693
G
MALAT1
metastasis associated lung adenocarcinoma transcript 1
IEP
mRNA:increased expression:cartilage tissue (human)
RGD
PMID:31472145
RGD:152177908
NCBI chr11:65,497,738...65,506,516
Ensembl chr11:65,497,606...65,508,073
G
MARCKS
myristoylated alanine rich protein kinase C substrate
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 6:113,857,345...113,863,475
Ensembl chr 6:113,857,345...113,863,475
G
MBD2
methyl-CpG binding domain protein 2
IEP
mRNA:increased expression:mononuclear cell
RGD
PMID:20937307
RGD:9588623
NCBI chr18:54,151,606...54,224,669
Ensembl chr18:54,151,606...54,224,669
G
MBD4
methyl-CpG binding domain 4, DNA glycosylase
susceptibility no_association
IAGP
DNA:snps:introns:IVS5-140A>G (rs3138355), IVS6-218C>T (rs2005618) (human) DNA:snps:cds, intron:p.E346K, IVS6-218C>T (rs140693, rs2005618) (human)
RGD
PMID:20676650 PMID:22505706
RGD:9588977 , RGD:9588978
NCBI chr 3:129,430,947...129,439,948
Ensembl chr 3:129,430,947...129,440,179
G
MDK
midkine
ISO
RGD
PMID:15146411
RGD:1581200
NCBI chr11:46,380,784...46,383,837
Ensembl chr11:46,380,756...46,383,837
G
MGARP
mitochondria localized glutamic acid rich protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 4:139,266,165...139,280,225
Ensembl chr 4:139,266,165...139,280,225
G
MIF
macrophage migration inhibitory factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16872482
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
G
MIR146A
microRNA 146a
IEP
mRNA:decreased expression:cartilage tissue (human) mRNA:increased expression:synovial (human)
RGD
PMID:31472145 PMID:22660635
RGD:152177908 , RGD:155663483
NCBI chr 5:160,485,352...160,485,450
Ensembl chr 5:160,485,352...160,485,450
G
MIR23B
microRNA 23b
IEP
mRNA, protein:decreased expression:synovial (human)
RGD
PMID:22660635
RGD:155663483
NCBI chr 9:95,085,208...95,085,304
Ensembl chr 9:95,085,208...95,085,304
G
MIR3936HG
MIR3936 host gene
IAGP
ClinVar Annotator: match by term: SLC22A4-related condition
ClinVar
PMID:19881261 PMID:25741868 PMID:26467025 PMID:28492532
NCBI chr 5:132,311,276...132,369,916
Ensembl chr 5:132,311,285...132,370,170
G
MMEL1
membrane metalloendopeptidase like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 1:2,590,639...2,633,016
Ensembl chr 1:2,590,639...2,633,016
G
MMP1
matrix metallopeptidase 1
IEP
protein:increased expression:plasma (human)
RGD
PMID:9972954
RGD:7207129
NCBI chr11:102,789,919...102,798,160
Ensembl chr11:102,789,401...102,798,160
G
MMP10
matrix metallopeptidase 10
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr11:102,770,502...102,780,628
Ensembl chr11:102,770,502...102,780,628
G
MMP12
matrix metallopeptidase 12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr11:102,862,736...102,874,982
Ensembl chr11:102,862,736...102,874,982
G
MMP14
matrix metallopeptidase 14
ISS
OMIM:180300
MouseDO
NCBI chr14:22,836,585...22,847,758
Ensembl chr14:22,836,560...22,849,041
G
MMP2
matrix metallopeptidase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16872482
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
G
MMP3
matrix metallopeptidase 3
disease_progression
IEP
protein:increased expression:serum (human)
RGD
PMID:7639798 PMID:22314025 PMID:11796404
RGD:7207128 , RGD:8693673 , RGD:7241254
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MMP8
matrix metallopeptidase 8
IEP
protein:increased expression:synovial fluid, serum (human)
RGD
PMID:15194590
RGD:7207131
NCBI chr11:102,711,796...102,724,954
Ensembl chr11:102,711,796...102,727,050
G
MMP9
matrix metallopeptidase 9
IEP
RGD
PMID:16406300
RGD:1582623
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MPO
myeloperoxidase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22450443 PMID:26001728
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MT-ND1
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1
IAGP
DNA:missense mutations:cds:multiple (human)
RGD
PMID:15987486
RGD:5490238
NCBI chr MT:3,307...4,262
Ensembl chr MT:3,307...4,262
G
MTHFR
methylenetetrahydrofolate reductase
IAGP EXP
DNA:SNP: :677C>T(human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:22104130 PMID:23685257
RGD:7387222
NCBI chr 1:11,785,723...11,805,964
Ensembl chr 1:11,785,723...11,806,455
G
NCF1
neutrophil cytosolic factor 1
induced
EXP ISO
CTD Direct Evidence: marker/mechanism DNA:polymorphism:M153T (rat)
CTD RGD
PMID:12833524 PMID:28135245 PMID:21275845
RGD:41404729
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
G
NCF2
neutrophil cytosolic factor 2
EXP IAGP
CTD Direct Evidence: marker/mechanism DNA:polymorphism, SNP:cds (rs789181) (human)
CTD RGD
PMID:12833524 PMID:17897462
RGD:41404710
NCBI chr 1:183,555,562...183,601,849
Ensembl chr 1:183,554,461...183,590,905
G
NCF4
neutrophil cytosolic factor 4
IAGP
DNA:polymorphism, SNP:cds (rs729749) (human)
RGD
PMID:17897462
RGD:41404710
NCBI chr22:36,861,006...36,878,015
Ensembl chr22:36,860,988...36,878,017
G
NDUFA4L2
NDUFA4 mitochondrial complex associated like 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr12:57,234,903...57,240,762
Ensembl chr12:57,234,903...57,240,715
G
NFKBIE
NFKB inhibitor epsilon
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr 6:44,258,166...44,265,551
Ensembl chr 6:44,258,166...44,265,788
G
NFKBIL1
NFKB inhibitor like 1
susceptibility
IAGP EXP
DNA:snp:promoter:c.-132T>A (rs2071592) (human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Rheumatoid arthritis
CTD OMIM ClinVar RGD
PMID:12509789 PMID:12509789
RGD:1331681
NCBI chr 6:31,546,851...31,558,829
Ensembl chr 6:31,546,870...31,558,829
G
NOTCH4
notch receptor 4
IEP
mRNA : increased expression: : cd4+ cells
RGD
PMID:20132067
RGD:6480790
NCBI chr 6:32,194,843...32,224,067
Ensembl chr 6:32,194,843...32,224,067
G
NPSR1
neuropeptide S receptor 1
IAGP
RGD
PMID:20179762
RGD:4891930
NCBI chr 7:34,658,218...34,878,332
Ensembl chr 7:34,658,218...34,878,332
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
mRNA:increased expression:paw
RGD
PMID:18448865
RGD:4892311
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NR4A3
nuclear receptor subfamily 4 group A member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
G
OPRM1
opioid receptor mu 1
susceptibility
IAGP
DNA:missense mutation:exon:p.N40D (118A>G) (rs 1799971) (human)
RGD
PMID:31309790
RGD:401827955
NCBI chr 6:154,010,496...154,246,867
Ensembl chr 6:154,010,496...154,246,867
G
PADI2
peptidyl arginine deiminase 2
IAGP
ClinVar Annotator: match by term: Rheumatoid arthritis
ClinVar
NCBI chr 1:17,066,761...17,119,451
Ensembl chr 1:17,066,761...17,119,451
G
PADI4
peptidyl arginine deiminase 4
EXP IAGP
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Rheumatoid arthritis
CTD ClinVar
PMID:23143596
NCBI chr 1:17,308,197...17,364,004
Ensembl chr 1:17,308,195...17,364,004
G
PDGFB
platelet derived growth factor subunit B
IEP
RGD
PMID:1708827
RGD:6482653
NCBI chr22:39,223,359...39,244,982
Ensembl chr22:39,223,359...39,244,982
G
PGF
placental growth factor
IEP
RGD
PMID:19180491
RGD:6483591
NCBI chr14:74,941,830...74,955,764
Ensembl chr14:74,941,834...74,955,626
G
PIK3R1
phosphoinositide-3-kinase regulatory subunit 1
IEP
mRNA:increased expression:cartilage tissue (human)
RGD
PMID:31472145
RGD:152177908
NCBI chr 5:68,215,756...68,301,821
Ensembl chr 5:68,215,740...68,301,821
G
PLA2G7
phospholipase A2 group VII
IEP
RGD
PMID:17326817
RGD:6482776
NCBI chr 6:46,704,201...46,735,721
Ensembl chr 6:46,704,201...46,735,693
G
PLAUR
plasminogen activator, urokinase receptor
IDA
RGD
PMID:22011479
RGD:6484117
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PLB1
phospholipase B1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24520335
NCBI chr 2:28,496,060...28,644,142
Ensembl chr 2:28,457,145...28,644,142
G
PLD4
phospholipase D family member 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr14:104,924,879...104,937,785
Ensembl chr14:104,924,713...104,937,761
G
PLEK
pleckstrin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 2:68,365,282...68,397,453
Ensembl chr 2:68,365,282...68,397,453
G
PON1
paraoxonase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:16055108
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
POU3F1
POU class 3 homeobox 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr 1:38,043,829...38,046,793
Ensembl chr 1:38,043,829...38,046,793
G
PRDM1
PR/SET domain 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19898481 PMID:20453842 PMID:23143596 PMID:36181686
NCBI chr 6:105,992,690...106,109,938
Ensembl chr 6:105,993,463...106,109,939
G
PRKCQ
protein kinase C theta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853 PMID:20453842 PMID:23143596
NCBI chr10:6,394,097...6,580,646
Ensembl chr10:6,427,143...6,580,301
G
PSG5
pregnancy specific beta-1-glycoprotein 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860
NCBI chr19:43,167,743...43,186,536
Ensembl chr19:43,166,256...43,186,536
G
PTGS1
prostaglandin-endoperoxide synthase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15167967
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
G
PTGS2
prostaglandin-endoperoxide synthase 2
IMP EXP
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:11978490 PMID:19192274 PMID:21905970
RGD:5508313
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
PTK2
protein tyrosine kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 8:140,657,900...141,002,079
Ensembl chr 8:140,657,900...141,002,216
G
PTPN2
protein tyrosine phosphatase non-receptor type 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:22446963
NCBI chr18:12,785,478...12,884,237
Ensembl chr18:12,785,478...12,929,643
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
susceptibility no_association
IAGP EXP
DNA:snp:cds:p.R620W (rs2476601) (human) ClinVar Annotator: match by term: Rheumatoid arthritis ClinVar Annotator: match by term: RHEUMATOID ARTHRITIS, SUSCEPTIBILITY TO CTD Direct Evidence: marker/mechanism DNA:SNP::1858C>T (human) DNA:snp:cds:p.R263Q (rs33996649) (human)
ClinVar OMIM CTD RGD
PMID:15004560 PMID:15208781 PMID:15273934 PMID:15580548 PMID:15719322 PMID:15744042 PMID:16273109 PMID:16339849 PMID:16470599 PMID:17170052 PMID:17436241 PMID:17554300 PMID:17878369 PMID:18301444 PMID:18978792 PMID:19265110 PMID:19430480 PMID:19898480 PMID:20453842 PMID:21190368 PMID:21841778 PMID:23143596 PMID:25741868 PMID:28492532 PMID:30224649 PMID:15208781 PMID:21467606 PMID:21279993 More...
RGD:6484535 , RGD:7829746 , RGD:6484595
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
G
PTPRC
protein tyrosine phosphatase receptor type C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 1:198,638,713...198,757,476
Ensembl chr 1:198,638,457...198,759,342
G
PXK
PX domain containing serine/threonine kinase like
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842
NCBI chr 3:58,332,892...58,426,127
Ensembl chr 3:58,332,880...58,426,127
G
RAB8A
RAB8A, member RAS oncogene family
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr19:16,111,889...16,134,234
Ensembl chr19:16,111,889...16,134,234
G
RAP2A
RAP2A, member of RAS oncogene family
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr13:97,434,169...97,469,128
Ensembl chr13:97,434,169...97,469,128
G
RASGRP1
RAS guanyl releasing protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr15:38,488,103...38,564,814
Ensembl chr15:38,488,103...38,565,575
G
RBPJ
recombination signal binding protein for immunoglobulin kappa J region
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 4:26,105,449...26,435,131
Ensembl chr 4:26,163,455...26,435,131
G
RCAN1
regulator of calcineurin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr21:34,516,442...34,615,113
Ensembl chr21:34,513,142...34,615,113
G
REL
REL proto-oncogene, NF-kB subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19503088 PMID:20453842 PMID:23143596
NCBI chr 2:60,881,574...60,931,612
Ensembl chr 2:60,881,491...60,931,612
G
RGMB
repulsive guidance molecule BMP co-receptor b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17568789
NCBI chr 5:98,768,632...98,796,494
Ensembl chr 5:98,768,650...98,798,643
G
RUNX1
RUNX family transcription factor 1
no_association
IAGP
DNA:SNPs: :rs2242720, rs4816502 (human) DNA:SNP: :rs2268277 (human) DNA:SNP:intron:24658G>C (human)
RGD
PMID:20018071 PMID:18087673 PMID:18328148 PMID:16821265
RGD:6482836 , RGD:6482840 , RGD:6482839 , RGD:6482837
NCBI chr21:35,372,507...35,580,764
Ensembl chr21:34,787,801...36,004,667
G
RUNX1
RUNX family transcription factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr21:34,787,801...35,049,302
Ensembl chr21:34,787,801...36,004,667
G
RUNX2
RUNX family transcription factor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr 6:45,328,330...45,551,082
Ensembl chr 6:45,328,157...45,664,349
G
SEMA3C
semaphorin 3C
IEP
protein:increased expression:knee, synovium (human)
RGD
PMID:15077297
RGD:1580084
NCBI chr 7:80,742,538...80,922,389
Ensembl chr 7:80,742,538...80,922,359
G
SLC11A1
solute carrier family 11 member 1
severity
IAGP EXP
DNA:polymorphism:promoter (human) CTD Direct Evidence: marker/mechanism DNA:polymorphisms, deletion: :823C>T, p.D543N (human)
CTD RGD
PMID:16597321 PMID:12135431 PMID:10719815
RGD:5684967 , RGD:5684971
NCBI chr 2:218,382,273...218,396,894
Ensembl chr 2:218,382,029...218,396,894
G
SLC22A4
solute carrier family 22 member 4
susceptibility
IAGP EXP
ClinVar Annotator: match by term: Rheumatoid arthritis ClinVar Annotator: match by term: SLC22A4-related condition CTD Direct Evidence: marker/mechanism
ClinVar CTD OMIM
PMID:14608356 PMID:19881261 PMID:25741868 PMID:26467025 PMID:28492532
NCBI chr 5:132,294,394...132,344,190
Ensembl chr 5:132,294,394...132,344,190
G
SLC25A12
solute carrier family 25 member 12
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 2:171,783,405...171,894,244
Ensembl chr 2:171,783,405...171,999,859
G
SMS
spermine synthase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr X:21,940,709...21,994,837
Ensembl chr X:21,940,709...21,994,837
G
SNHG14
small nucleolar RNA host gene 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:34529319
NCBI chr15:24,823,608...25,419,462
Ensembl chr15:24,978,583...25,420,336
G
SOD2
superoxide dismutase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524 PMID:15292528 PMID:24313545
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
G
SPP1
secreted phosphoprotein 1
IDA
RGD
PMID:15761492
RGD:1581382
NCBI chr 4:87,975,714...87,983,411
Ensembl chr 4:87,975,667...87,983,532
G
SPRED2
sprouty related EVH1 domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 2:65,307,175...65,432,599
Ensembl chr 2:65,310,851...65,432,637
G
ST6GALNAC5
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:17379860 PMID:17568789
NCBI chr 1:76,867,480...77,067,546
Ensembl chr 1:76,867,480...77,067,546
G
STAT1
signal transducer and activator of transcription 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr 2:190,969,149...191,014,171
Ensembl chr 2:190,908,460...191,020,960
G
STAT3
signal transducer and activator of transcription 3
IAGP
associated with T-cell large granular lymphocyte leukemia
RGD
PMID:22591296
RGD:6892936
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STAT4
signal transducer and activator of transcription 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435
G
STS
steroid sulfatase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr X:7,147,290...7,354,641
Ensembl chr X:7,147,237...7,804,358
G
SUPT20H
SPT20 homolog, SAGA complex component
IAGP
ClinVar Annotator: match by term: Rheumatoid arthritis
ClinVar
NCBI chr13:37,009,312...37,059,688
Ensembl chr13:37,009,312...37,059,713
G
TAB2
TGF-beta activated kinase 1 (MAP3K7) binding protein 2
IEP
mRNA, protein:increased expression:synovial (human)
RGD
PMID:22660635
RGD:155663483
NCBI chr 6:149,217,926...149,411,607
Ensembl chr 6:149,218,641...149,411,613
G
TAB3
TGF-beta activated kinase 1 (MAP3K7) binding protein 3
IEP
mRNA, protein:increased expression:synovial (human)
RGD
PMID:22660635
RGD:155663483
NCBI chr X:30,827,442...30,889,254
Ensembl chr X:30,827,442...30,975,084
G
TAGAP
T cell activation RhoGTPase activating protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr 6:159,034,481...159,044,991
Ensembl chr 6:159,034,468...159,095,823
G
TAP2
transporter 2, ATP binding cassette subfamily B member
IAGP
RGD
PMID:9645419
RGD:6482275
NCBI chr 6:32,821,831...32,838,739
Ensembl chr 6:32,821,833...32,838,739
G
TFPI2
tissue factor pathway inhibitor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:15292528 PMID:17379860
NCBI chr 7:93,885,396...93,890,753
Ensembl chr 7:93,885,396...93,890,753
G
THBD
thrombomodulin
IDA
RGD
PMID:15700117
RGD:5685020
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
TLE3
TLE family member 3, transcriptional corepressor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596
NCBI chr15:70,047,790...70,097,917
Ensembl chr15:70,047,790...70,098,176
G
TLR1
toll like receptor 1
IAGP
ClinVar Annotator: match by term: Rheumatoid arthritis
ClinVar
PMID:32594150
NCBI chr 4:38,787,569...38,805,644
Ensembl chr 4:38,787,555...38,856,817
G
TLR2
toll like receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 4:153,684,280...153,710,637
Ensembl chr 4:153,684,050...153,706,260
G
TMPO
thymopoietin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:12833524
NCBI chr12:98,515,573...98,550,351
Ensembl chr12:98,515,561...98,550,351
G
TNF
tumor necrosis factor
treatment no_association
IMP ISS IEP EXP IAGP
OMIM:180300 mRNA:increased expression:synovial (human) CTD Direct Evidence: marker/mechanism|therapeutic DNA:SNP:promoter:-238G>A, -308G>A (human) DNA:SNP:promoter:-857C>T (human)
MouseDO CTD RGD
PMID:2001072 PMID:8391952 PMID:12566094 PMID:22450443 PMID:34459104 PMID:12563673 PMID:22660635 PMID:25311255 PMID:25311255 More...
RGD:10450537 , RGD:155663483 , RGD:12904065 , RGD:12904065
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP2
TNF alpha induced protein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr14:103,121,469...103,137,439
Ensembl chr14:103,121,476...103,137,439
G
TNFAIP3
TNF alpha induced protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853 PMID:20453842 PMID:21841782 PMID:23143596 PMID:30224649
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
TNFRSF11B
TNF receptor superfamily member 11b
EXP
CTD Direct Evidence: therapeutic
CTD
PMID:23333834
NCBI chr 8:118,923,557...118,951,885
Ensembl chr 8:118,923,557...118,951,885
G
TNFRSF14
TNF receptor superfamily member 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842
NCBI chr 1:2,554,234...2,563,829
Ensembl chr 1:2,555,639...2,565,382
G
TNFRSF1A
TNF receptor superfamily member 1A
treatment
IAGP
DNA:SNP:promoter:36G>A (human)
RGD
PMID:25311255
RGD:12904065
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
G
TNFSF14
TNF superfamily member 14
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20008919
NCBI chr19:6,661,253...6,670,588
Ensembl chr19:6,658,085...6,670,588
G
TRAF1
TNF receptor associated factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:18794853 PMID:23143596
NCBI chr 9:120,902,393...120,929,171
Ensembl chr 9:120,902,393...120,929,173
G
TRAF6
TNF receptor associated factor 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:20453842 PMID:23143596
NCBI chr11:36,483,769...36,510,272
Ensembl chr11:36,483,769...36,510,272
G
TREM1
triggering receptor expressed on myeloid cells 1
treatment
ISO
RGD
PMID:27049384
RGD:127229930
NCBI chr 6:41,267,385...41,286,682
Ensembl chr 6:41,267,100...41,286,682
G
TXNDC5
thioredoxin domain containing 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23326410
NCBI chr 6:7,881,517...7,910,788
Ensembl chr 6:7,881,517...7,910,788
G
TXNIP
thioredoxin interacting protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19192274
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
G
TYK2
tyrosine kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:23143596 PMID:30224649
NCBI chr19:10,350,533...10,380,572
Ensembl chr19:10,350,528...10,380,608
G
TYMS
thymidylate synthetase
treatment
IAGP
DNA:polymorphism: :
RGD
PMID:22763757
RGD:11075093
NCBI chr18:657,653...673,578
Ensembl chr18:657,653...673,578
G
TYROBP
transmembrane immune signaling adaptor TYROBP
treatment
ISO
RGD
PMID:27049384
RGD:127229930
NCBI chr19:35,904,403...35,908,295
Ensembl chr19:35,904,401...35,908,295
G
VDR
vitamin D receptor
no_association
IAGP
DNA:SNP:exon:rs2228570 (human) DNA:SNP: :rs1544410 (human)
RGD
PMID:21820934 PMID:21820934
RGD:8158077 , RGD:8158077
NCBI chr12:47,841,537...47,904,994
Ensembl chr12:47,841,537...47,943,048
G
VEGFA
vascular endothelial growth factor A
disease_progression
IEP EXP
protein:increased expression:serum: CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16368150 PMID:24387171
RGD:8548659
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
VIM
vimentin
IDA
RGD
PMID:21792832
RGD:6480508
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
ZAP70
zeta chain of T cell receptor associated protein kinase 70
ISS
OMIM:180300
MouseDO
NCBI chr 2:97,713,576...97,756,364
Ensembl chr 2:97,713,576...97,744,327
G
ZFP36
ZFP36 ring finger protein
ISS
OMIM:180300
MouseDO
NCBI chr19:39,406,847...39,409,407
Ensembl chr19:39,406,847...39,409,407
G
HGF
hepatocyte growth factor
IEP
protein:increased expression:serum:
RGD
PMID:24387171
RGD:8548659
NCBI chr 7:81,699,010...81,770,047
Ensembl chr 7:81,699,010...81,770,438
G
VEGFA
vascular endothelial growth factor A
IEP
protein:increased expression:serum:
RGD
PMID:24387171
RGD:8548659
NCBI chr 6:43,770,211...43,786,487
Ensembl chr 6:43,770,184...43,786,487
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility
IAGP
DNA:polymorphism: :HLA-DRB1*1104, HLA-DRB1*080(human)
RGD
PMID:7955632
RGD:7365102
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
ACP3
acid phosphatase 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:132,317,407...132,368,302
Ensembl chr 3:132,317,369...132,368,302
G
ACRBP
acrosin binding protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:6,638,075...6,647,432
Ensembl chr12:6,638,075...6,647,433
G
ADCY7
adenylate cyclase 7
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr16:50,244,699...50,318,135
Ensembl chr16:50,246,137...50,318,135
G
ALOX12
arachidonate 12-lipoxygenase, 12S type
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:6,996,049...7,010,754
Ensembl chr17:6,996,049...7,010,754
G
ANKRD9
ankyrin repeat domain 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:102,501,767...102,509,776
Ensembl chr14:102,501,767...102,509,799
G
AOPEP
aminopeptidase O (putative)
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:94,726,699...95,150,224
Ensembl chr 9:94,726,604...95,151,793
G
APOBEC3A
apolipoprotein B mRNA editing enzyme catalytic subunit 3A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr22:38,957,609...38,963,184
Ensembl chr22:38,952,741...38,963,184
G
AQP9
aquaporin 9
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr15:58,138,169...58,185,911
Ensembl chr15:58,138,169...58,185,911
G
AREG
amphiregulin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:74,445,136...74,455,005
Ensembl chr 4:74,445,136...74,455,005
G
ASAP1
ArfGAP with SH3 domain, ankyrin repeat and PH domain 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:130,052,104...130,443,674
Ensembl chr 8:130,052,104...130,443,674
G
AVL9
AVL9 cell migration associated
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:32,495,489...32,588,726
Ensembl chr 7:32,495,426...32,588,726
G
B4GALT5
beta-1,4-galactosyltransferase 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr20:49,632,945...49,713,878
Ensembl chr20:49,632,945...49,713,878
G
BEND2
BEN domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr X:18,162,931...18,220,886
Ensembl chr X:18,162,931...18,220,886
G
BLTP3B
bridge-like lipid transfer protein family member 3B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:100,037,072...100,142,874
Ensembl chr12:100,028,455...100,142,874
G
BTG1
BTG anti-proliferation factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:92,140,278...92,145,846
Ensembl chr12:92,140,278...92,145,846
G
BTG3
BTG anti-proliferation factor 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr21:17,593,653...17,612,901
Ensembl chr21:17,593,653...17,612,945
G
C2orf88
chromosome 2 open reading frame 88
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:189,879,562...190,203,484
Ensembl chr 2:189,879,609...190,203,484
G
C8B
complement C8 beta chain
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:7980680
NCBI chr 1:56,929,207...56,966,015
Ensembl chr 1:56,929,207...56,974,383
G
C9orf72
C9orf72-SMCR8 complex subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:27,546,546...27,573,866
Ensembl chr 9:27,535,640...27,573,866
G
CALD1
caldesmon 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:134,745,467...134,970,729
Ensembl chr 7:134,744,252...134,970,729
G
CAMSAP1
calmodulin regulated spectrin associated protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:135,808,487...135,907,546
Ensembl chr 9:135,808,487...135,907,546
G
CCDC122
coiled-coil domain containing 122
IAGP
ClinVar Annotator: match by term: JUVENILE ARTHRITIS
ClinVar
PMID:25741868
NCBI chr13:43,819,018...43,879,740
Ensembl chr13:43,823,909...43,879,740
G
CCR5
C-C motif chemokine receptor 5
no_association
IAGP
DNA:polymorphisms: :multiple (human) DNA:frameshift mutation:cds:p.S185_T195del rs333 (human)
RGD
PMID:16775617 PMID:17565662
RGD:1626284 , RGD:1626283
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CD14
CD14 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:140,631,732...140,633,701
Ensembl chr 5:140,631,728...140,633,700
G
CD83
CD83 molecule
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:14,117,256...14,136,918
Ensembl chr 6:14,117,256...14,140,682
G
CD8B
CD8 subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:86,815,369...86,861,886
Ensembl chr 2:86,815,339...86,861,924
G
CIITA
class II major histocompatibility complex transactivator
susceptibility no_association
IAGP
DNA:polymorphism:exon:1614G>C (human) DNA:polymorphism:promoter:rs3087456, no association in a German cohort
RGD
PMID:17661914 PMID:16426246
RGD:5491187 , RGD:5491189
NCBI chr16:10,866,206...10,943,021
Ensembl chr16:10,866,222...10,943,021
G
CLU
clusterin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:27,596,917...27,614,700
Ensembl chr 8:27,596,917...27,614,700
G
CMTM2
CKLF like MARVEL transmembrane domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr16:66,579,463...66,588,275
Ensembl chr16:66,579,448...66,588,275
G
CREM
cAMP responsive element modulator
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:35,126,846...35,212,958
Ensembl chr10:35,126,791...35,212,958
G
CRP
C-reactive protein
IEP
protein:increased expression:serum
RGD
PMID:22885951
RGD:6906884
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CTTN
cortactin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:70,398,529...70,436,575
Ensembl chr11:70,398,404...70,436,584
G
CXCL1
C-X-C motif chemokine ligand 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:73,869,393...73,871,308
Ensembl chr 4:73,869,393...73,871,308
G
CXCR2
C-X-C motif chemokine receptor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:218,125,294...218,137,251
Ensembl chr 2:218,125,289...218,137,251
G
CXCR4
C-X-C motif chemokine receptor 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504 PMID:26387944
NCBI chr 2:136,114,349...136,118,149
Ensembl chr 2:136,114,349...136,119,177
G
DAPK1
death associated protein kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:87,497,228...87,708,634
Ensembl chr 9:87,497,228...87,708,634
G
DDIT3
DNA damage inducible transcript 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:57,516,588...57,520,517
Ensembl chr12:57,516,588...57,521,737
G
DUSP1
dual specificity phosphatase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:172,768,096...172,771,195
Ensembl chr 5:172,768,096...172,771,195
G
DUSP2
dual specificity phosphatase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:96,143,169...96,145,440
Ensembl chr 2:96,143,166...96,145,440
G
DUSP4
dual specificity phosphatase 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:29,333,064...29,350,684
Ensembl chr 8:29,333,064...29,350,684
G
DYSF
dysferlin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:71,453,561...71,686,763
Ensembl chr 2:71,453,561...71,686,763
G
EGF
epidermal growth factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:109,912,883...110,013,766
Ensembl chr 4:109,912,883...110,013,766
G
EGR1
early growth response 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
G
ELF2
E74 like ETS transcription factor 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:139,057,220...139,177,915
Ensembl chr 4:139,028,112...139,177,218
G
ETNK1
ethanolamine kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:22,625,171...22,690,665
Ensembl chr12:22,625,075...22,690,665
G
ETV6
ETS variant transcription factor 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:11,649,674...11,895,377
Ensembl chr12:11,649,674...11,895,377
G
FAM20A
FAM20A golgi associated secretory pathway pseudokinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:68,535,116...68,601,367
Ensembl chr17:68,535,113...68,601,367
G
FAXDC2
fatty acid hydroxylase domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:154,818,492...154,850,603
Ensembl chr 5:154,818,492...154,859,252
G
FCGR1A
Fc gamma receptor Ia
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:149,782,694...149,800,609
Ensembl chr 1:149,782,671...149,791,675
G
FCHSD2
FCH and double SH3 domains 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:72,836,745...73,142,318
Ensembl chr11:72,836,745...73,142,318
G
FOS
Fos proto-oncogene, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:75,278,828...75,282,230
Ensembl chr14:75,278,826...75,283,190
G
FOSB
FosB proto-oncogene, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr19:45,467,996...45,475,179
Ensembl chr19:45,467,995...45,475,179
G
FOSL2
FOS like 2, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:28,392,858...28,417,317
Ensembl chr 2:28,392,448...28,417,317
G
FOXP1
forkhead box P1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:70,954,708...71,583,978
Ensembl chr 3:70,954,693...71,583,978
G
GADD45A
growth arrest and DNA damage inducible alpha
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:67,685,201...67,688,334
Ensembl chr 1:67,685,201...67,688,334
G
GMPR
guanosine monophosphate reductase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:16,238,587...16,295,549
Ensembl chr 6:16,238,587...16,295,549
G
GNG11
G protein subunit gamma 11
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:93,921,735...93,928,610
Ensembl chr 7:93,921,735...93,928,610
G
GP1BB
glycoprotein Ib platelet subunit beta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr22:19,723,539...19,724,771
Ensembl chr22:19,723,539...19,724,771
G
GSTT1
glutathione S-transferase theta 1
susceptibility
IAGP
DNA:deletion: :
RGD
PMID:18328165
RGD:5490992
G
H2AC8
H2A clustered histone 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:26,216,921...26,217,437
Ensembl chr 6:26,216,921...26,218,515
G
H2BC8
H2B clustered histone 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:26,216,200...26,216,688
Ensembl chr 6:26,216,200...26,216,688
G
HBEGF
heparin binding EGF like growth factor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:140,332,843...140,346,603
Ensembl chr 5:140,332,843...140,346,603
G
HERPUD2
HERPUD family member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:35,632,659...35,695,135
Ensembl chr 7:35,632,659...35,697,459
G
HFE
homeostatic iron regulator
IAGP
DNA:missense mutation:cds:p.C282Y (human)
RGD
PMID:16047841
RGD:8694357
NCBI chr 6:26,087,429...26,098,343
Ensembl chr 6:26,087,226...26,098,343
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
IEP IAGP
DNA:polymorphism (human)
RGD
PMID:19811310 PMID:10457895
RGD:5147815 , RGD:5147863
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
IAGP
DNA:polymorphism (human)
RGD
PMID:10457895
RGD:5147863
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
IAGP
DNA:polymorphism (human)
RGD
PMID:19908388 PMID:10457895
RGD:5147587 , RGD:5147863
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HSPA6
heat shock protein family A (Hsp70) member 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:161,524,540...161,526,894
Ensembl chr 1:161,524,540...161,526,894
G
HSPD1
heat shock protein family D (Hsp60) member 1
IEP
protein:increased expression:serum,synovial fluid:
RGD
PMID:8255671
RGD:12910480
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
IGF1R
insulin like growth factor 1 receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr15:98,648,539...98,964,530
Ensembl chr15:98,648,539...98,964,530
G
IL1A
interleukin 1 alpha
IAGP
DNA:SNP:promoter:-889C>T (human)
RGD
PMID:8162643
RGD:7794716
NCBI chr 2:112,773,925...112,784,493
Ensembl chr 2:112,773,925...112,784,493
G
IL1RN
interleukin 1 receptor antagonist
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2
interleukin 2
IEP
protein:increased expression:mononuclear cell
RGD
PMID:21859687
RGD:5147870
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL6
interleukin 6
IEP
protein:increased expression:serum:
RGD
PMID:9489833
RGD:7829742
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
ITGA2B
integrin subunit alpha 2b
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:44,372,181...44,389,649
Ensembl chr17:44,372,180...44,389,649
G
ITGB5
integrin subunit beta 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:124,761,948...124,901,418
Ensembl chr 3:124,761,948...124,901,418
G
JMJD1C
jumonji domain containing 1C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:63,167,225...63,521,890
Ensembl chr10:63,167,221...63,521,850
G
JUN
Jun proto-oncogene, AP-1 transcription factor subunit
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:58,780,791...58,784,047
Ensembl chr 1:58,776,845...58,784,048
G
KAT6B
lysine acetyltransferase 6B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:74,824,936...75,032,624
Ensembl chr10:74,824,927...75,032,624
G
KCNJ15
potassium inwardly rectifying channel subfamily J member 15
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr21:38,229,926...38,307,357
Ensembl chr21:38,155,549...38,307,357
G
KLF4
KLF transcription factor 4
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:107,484,852...107,489,769
Ensembl chr 9:107,484,852...107,490,482
G
KRAS
KRAS proto-oncogene, GTPase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:25,205,246...25,250,929
Ensembl chr12:25,205,246...25,250,936
G
LACC1
laccase domain containing 1
IAGP
ClinVar Annotator: match by term: JUVENILE ARTHRITIS
OMIM ClinVar
PMID:25147203 PMID:25220867 PMID:25741868 PMID:27881174 PMID:29717096 PMID:31811059 More...
NCBI chr13:43,879,178...43,893,932
Ensembl chr13:43,879,284...43,893,932
G
LILRA5
leukocyte immunoglobulin like receptor A5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr19:54,307,070...54,313,166
Ensembl chr19:54,307,070...54,313,166
G
LPP
LIM domain containing preferred translocation partner in lipoma
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:188,153,021...188,890,671
Ensembl chr 3:188,153,284...188,890,671
G
MAD1L1
mitotic arrest deficient 1 like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:1,815,795...2,232,945
Ensembl chr 7:1,815,793...2,233,243
G
MAFF
MAF bZIP transcription factor F
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr22:38,201,994...38,216,511
Ensembl chr22:38,200,767...38,216,507
G
MAML2
mastermind like transcriptional coactivator 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:95,976,598...96,343,195
Ensembl chr11:95,976,598...96,343,195
G
MAP2
microtubule associated protein 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:209,424,047...209,734,112
Ensembl chr 2:209,424,047...209,734,147
G
MAPK1
mitogen-activated protein kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MBL2
mannose binding lectin 2
IEP
RGD
PMID:18334024
RGD:12910845
NCBI chr10:52,765,380...52,772,784
Ensembl chr10:52,765,380...52,772,784
G
MEX3C
mex-3 RNA binding family member C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr18:51,174,550...51,197,681
Ensembl chr18:51,174,550...51,218,333
G
MIR22HG
MIR22 host gene
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:1,711,504...1,716,210
Ensembl chr17:1,711,447...1,717,174
G
MS4A4A
membrane spanning 4-domains A4A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:60,280,666...60,308,970
Ensembl chr11:60,185,657...60,318,080
G
MSN
moesin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr X:65,588,377...65,741,931
Ensembl chr X:65,588,377...65,741,931
G
MTSS1
MTSS I-BAR domain containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:124,550,784...124,728,473
Ensembl chr 8:124,550,784...124,728,473
G
MYZAP
myocardial zonula adherens protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr15:57,591,904...57,685,364
Ensembl chr15:57,591,904...57,685,364
G
NDEL1
nudE neurodevelopment protein 1 like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:8,413,131...8,474,328
Ensembl chr17:8,413,131...8,490,411
G
NEAT1
nuclear paraspeckle assembly transcript 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:65,422,798...65,445,540
Ensembl chr11:65,422,278...65,445,540
G
NR4A2
nuclear receptor subfamily 4 group A member 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:156,324,437...156,332,721
Ensembl chr 2:156,324,437...156,342,348
G
NR4A3
nuclear receptor subfamily 4 group A member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:99,821,885...99,866,891
Ensembl chr 9:99,821,855...99,866,891
G
NRG1
neuregulin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:31,639,245...32,774,046
Ensembl chr 8:31,639,222...32,855,666
G
OLR1
oxidized low density lipoprotein receptor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:10,158,301...10,176,266
Ensembl chr12:10,158,301...10,172,138
G
OSM
oncostatin M
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr22:30,262,829...30,266,851
Ensembl chr22:30,262,829...30,266,851
G
PACSIN2
protein kinase C and casein kinase substrate in neurons 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr22:42,869,766...43,015,149
Ensembl chr22:42,835,412...43,015,149
G
PCYT1B
phosphate cytidylyltransferase 1B, choline
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr X:24,558,087...24,672,887
Ensembl chr X:24,558,087...24,672,677
G
PER1
period circadian regulator 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:8,140,472...8,152,404
Ensembl chr17:8,140,467...8,156,506
G
PGM5
phosphoglucomutase 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 9:68,356,611...68,531,061
Ensembl chr 9:68,328,308...68,531,061
G
PLAUR
plasminogen activator, urokinase receptor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr19:43,646,095...43,670,169
Ensembl chr19:43,646,095...43,670,547
G
PLK2
polo like kinase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:58,453,982...58,460,086
Ensembl chr 5:58,453,982...58,460,139
G
PLOD2
procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:146,069,440...146,161,184
Ensembl chr 3:146,035,139...146,163,725
G
PROS1
protein S
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:93,873,051...93,973,896
Ensembl chr 3:93,873,051...93,980,003
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
IAGP
DNA: snp : cds : rs2476601
RGD
PMID:15934099
RGD:6484550
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
G
R3HDM2
R3H domain containing 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:57,253,764...57,431,141
Ensembl chr12:57,253,762...57,431,043
G
RASGEF1B
RasGEF domain family member 1B
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:81,426,393...81,471,907
Ensembl chr 4:81,426,393...82,044,244
G
RBM47
RNA binding motif protein 47
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 4:40,423,280...40,630,852
Ensembl chr 4:40,423,267...40,630,875
G
RERE
arginine-glutamic acid dipeptide repeats
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 1:8,352,404...8,817,640
Ensembl chr 1:8,352,397...8,848,921
G
RHOBTB1
Rho related BTB domain containing 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:60,860,860...61,001,967
Ensembl chr10:60,869,438...61,001,440
G
RNF103
ring finger protein 103
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:86,603,393...86,623,877
Ensembl chr 2:86,603,398...86,623,866
G
SELP
selectin P
severity
IEP
protein:increased expression:plasma
RGD
PMID:21124648
RGD:6219006
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
SH2D2A
SH2 domain containing 2A
IAGP
DNA:polymorphism:promoter
RGD
PMID:15129233
RGD:2298870
NCBI chr 1:156,806,243...156,816,848
Ensembl chr 1:156,806,240...156,816,848
G
SH3BGRL2
SH3 domain binding glutamate rich protein like 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:79,537,633...79,703,655
Ensembl chr 6:79,537,185...79,703,655
G
SIK1
salt inducible kinase 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr21:43,414,483...43,427,131
Ensembl chr21:43,414,483...43,427,131
G
SIPA1L1
signal induced proliferation associated 1 like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:71,320,476...71,741,209
Ensembl chr14:71,320,449...71,741,229
G
SLC11A1
solute carrier family 11 member 1
IAGP EXP
DNA:repeat:promoter (human) CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:16597321 PMID:10857800
RGD:5684977
NCBI chr 2:218,382,273...218,396,894
Ensembl chr 2:218,382,029...218,396,894
G
SLC22A16
solute carrier family 22 member 16
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:110,424,687...110,476,613
Ensembl chr 6:110,424,687...110,476,641
G
SLC26A2
solute carrier family 26 member 2
susceptibility
IAGP
DNA:SNPs: :
RGD
PMID:17393463
RGD:13208931
NCBI chr 5:149,960,758...149,987,400
Ensembl chr 5:149,960,758...149,993,455
G
SLC2A3
solute carrier family 2 member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:7,919,230...7,936,187
Ensembl chr12:7,919,230...8,019,007
G
SMAD3
SMAD family member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr15:67,065,602...67,195,169
Ensembl chr15:67,063,763...67,195,173
G
STAB1
stabilin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:52,495,338...52,524,495
Ensembl chr 3:52,495,338...52,524,495
G
STAT3
signal transducer and activator of transcription 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr17:42,313,324...42,388,442
Ensembl chr17:42,313,324...42,388,568
G
STIM1
stromal interaction molecule 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr11:3,854,604...4,093,210
Ensembl chr11:3,854,527...4,093,210
G
TCF7L2
transcription factor 7 like 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr10:112,950,247...113,167,678
Ensembl chr10:112,950,247...113,167,678
G
TFDP1
transcription factor Dp-1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr13:113,584,688...113,641,473
Ensembl chr13:113,584,721...113,641,473
G
TFPI
tissue factor pathway inhibitor
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:187,464,230...187,554,435
Ensembl chr 2:187,464,230...187,565,760
G
THBD
thrombomodulin
IEP
protein:increased expression:serum
RGD
PMID:15209962
RGD:5685023
NCBI chr20:23,045,633...23,049,672
Ensembl chr20:23,045,633...23,049,672
G
THBS1
thrombospondin 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
TNFAIP6
TNF alpha induced protein 6
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 2:151,357,592...151,381,340
Ensembl chr 2:151,357,592...151,380,046
G
TNFAIP8
TNF alpha induced protein 8
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 5:119,268,759...119,399,688
Ensembl chr 5:119,268,692...119,399,688
G
TNFRSF10C
TNF receptor superfamily member 10c
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 8:23,102,921...23,117,445
Ensembl chr 8:23,102,921...23,117,445
G
TNIK
TRAF2 and NCK interacting kinase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:171,058,414...171,460,408
Ensembl chr 3:171,058,414...171,460,408
G
TREML1
triggering receptor expressed on myeloid cells like 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:41,149,260...41,155,403
Ensembl chr 6:41,149,337...41,154,347
G
TTLL5
tubulin tyrosine ligase like 5
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr14:75,661,246...75,955,079
Ensembl chr14:75,633,625...75,955,079
G
TUBB2A
tubulin beta 2A class IIa
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:3,153,666...3,157,544
Ensembl chr 6:3,153,497...3,157,544
G
UBE2E1
ubiquitin conjugating enzyme E2 E1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 3:23,805,955...23,891,640
Ensembl chr 3:23,805,955...23,891,640
G
UBE3C
ubiquitin protein ligase E3C
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 7:157,138,926...157,269,370
Ensembl chr 7:157,138,926...157,269,370
G
WASF3
WASP family member 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr13:26,539,139...26,688,948
Ensembl chr13:26,557,683...26,688,948
G
WWOX
WW domain containing oxidoreductase
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr16:78,099,654...79,212,667
Ensembl chr16:78,099,400...79,212,667
G
ZFAND3
zinc finger AN1-type containing 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr 6:37,819,727...38,154,624
Ensembl chr 6:37,819,727...38,154,624
G
ZFC3H1
zinc finger C3H1-type containing
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:19565504
NCBI chr12:71,609,599...71,663,848
Ensembl chr12:71,609,599...71,667,725
G
AIRE
autoimmune regulator
ISS
OMIM:270150
MouseDO
NCBI chr21:44,285,876...44,298,648
Ensembl chr21:44,285,838...44,298,648
G
APOE
apolipoprotein E
onset
IAGP
DNA:polymorphism:exon:
RGD
PMID:15328426
RGD:7495765
NCBI chr19:44,905,796...44,909,393
Ensembl chr19:44,905,791...44,909,393
G
BDNF
brain derived neurotrophic factor
severity
IEP
protein:increased expression:serum:
RGD
PMID:18830907
RGD:8657019
NCBI chr11:27,654,893...27,722,030
Ensembl chr11:27,654,893...27,722,058
G
BST2
bone marrow stromal cell antigen 2
IEP
mRNA, protein:increased expression: labial gland, CD19+ B cell, CD4-CD8-CD19-monocyte:
RGD
PMID:30249485
RGD:14398821
NCBI chr19:17,402,939...17,405,630
Ensembl chr19:17,402,939...17,405,630
G
C3
complement C3
ISO
RGD
PMID:17675493
RGD:7401265
NCBI chr19:6,677,704...6,720,650
Ensembl chr19:6,677,704...6,730,562
G
CA1
carbonic anhydrase 1
IDA
RGD
PMID:12806141
RGD:408425977
NCBI chr 8:85,327,608...85,378,113
Ensembl chr 8:85,327,608...85,379,014
G
CA2
carbonic anhydrase 2
IDA
RGD
PMID:15831920 PMID:12806141
RGD:408425973 , RGD:408425977
NCBI chr 8:85,464,007...85,481,493
Ensembl chr 8:85,463,968...85,481,493
G
CAST
calpastatin
IDA
associated with Lupus Erythematosus, Systemic
RGD
PMID:15540513
RGD:5683622
NCBI chr 5:95,961,429...96,774,683
Ensembl chr 5:96,247,756...96,779,595 Ensembl chr 5:96,247,756...96,779,595
G
CCR5
C-C motif chemokine receptor 5
no_association
IAGP
DNA:frameshift mutation: :p.S185_T195del (rs333) (human)
RGD
PMID:12412204 PMID:23773920
RGD:8551796 , RGD:8551818
NCBI chr 3:46,370,142...46,376,206
Ensembl chr 3:46,370,946...46,376,206
G
CCR7
C-C motif chemokine receptor 7
ISS
OMIM:270150
MouseDO
NCBI chr17:40,553,769...40,565,472
Ensembl chr17:40,551,081...40,565,472
G
CD40LG
CD40 ligand
IEP
protein:increased expression:salivary ductal epithelium (human)
RGD
PMID:12472667
RGD:11520791
NCBI chr X:136,648,158...136,660,390
Ensembl chr X:136,648,158...136,660,390
G
CRP
C-reactive protein
IEP
associated with Arthritis, Rheumatoid;protein:increased expression:serum:
RGD
PMID:2353152 PMID:16013223
RGD:9491774 , RGD:9491835
NCBI chr 1:159,712,289...159,714,589
Ensembl chr 1:159,712,289...159,714,589
G
CTLA4
cytotoxic T-lymphocyte associated protein 4
susceptibility
IAGP IEP
DNA:SNPs,haplotype: :+49A/G (rs231775),(rs3087243)(human) mRNA:increased expression:salivary gland:
RGD
PMID:16869018 PMID:12528117
RGD:7421506 , RGD:7421519
NCBI chr 2:203,867,771...203,873,965
Ensembl chr 2:203,853,888...203,873,965
G
CYP19A1
cytochrome P450 family 19 subfamily A member 1
ISS
OMIM:270150
MouseDO
NCBI chr15:51,208,057...51,338,596
Ensembl chr15:51,208,057...51,338,601
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
IAGP
associated with Arthritis, Rheumatoid;DNA:polymorphism: :4889A>G (human)
RGD
PMID:12590982
RGD:5147747
NCBI chr15:74,719,542...74,725,528
Ensembl chr15:74,719,542...74,725,536
G
DGKQ
diacylglycerol kinase theta
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 4:958,887...973,569
Ensembl chr 4:958,887...986,895
G
E2F1
E2F transcription factor 1
ISS
OMIM:270150
MouseDO
NCBI chr20:33,675,477...33,686,385
Ensembl chr20:33,675,477...33,686,385
G
FAS
Fas cell surface death receptor
IEP ISS ISO
protein:increased expression:serum (human) OMIM:270150 protein:decreased expression:lacrimal gland, lymphocyte (mouse)
MouseDO RGD
PMID:9890678 PMID:9870874 PMID:11157873
RGD:8662410 , RGD:8662451 , RGD:8662436
NCBI chr10:88,964,050...89,017,059
Ensembl chr10:88,953,813...89,029,605
G
FCGR2A
Fc gamma receptor IIa
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 1:161,505,457...161,524,048
Ensembl chr 1:161,505,430...161,524,013
G
GDNF
glial cell derived neurotrophic factor
IEP
RGD
PMID:9853108
RGD:6218983
NCBI chr 5:37,812,677...37,840,041
Ensembl chr 5:37,812,677...37,840,041
G
GTF2I
general transcription factor IIi
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097066
NCBI chr 7:74,657,718...74,760,692
Ensembl chr 7:74,650,231...74,760,692
G
HLA-DQA1
major histocompatibility complex, class II, DQ alpha 1
susceptibility
IAGP
DNA:polymorphism:cds:HLA-DQA1*0101 (human) DNA:polymorphisms::HLA-DQA1*0501,LA-DQA1*0301/2;
RGD
PMID:11555411 PMID:21315052
RGD:5147809 , RGD:7421543
NCBI chr 6:32,637,406...32,655,272
Ensembl chr 6:32,628,179...32,647,062
G
HLA-DQB1
major histocompatibility complex, class II, DQ beta 1
susceptibility
IAGP
DNA:polymorphisms:cds:HLA-DQB1*0201 (human) associated with Chronic Hepatitis C;DNA:polymorphism:cds:HLA-DQB1*02 (human) DNA:polymorphisms, haplotypes:cds:HLA-DQB1*0201, HLA-DQB1*0401, HLA-DQB1*0601 (human)
RGD
PMID:21315052 PMID:17489060 PMID:8468491
RGD:7421543 , RGD:36174022 , RGD:7483566
NCBI chr 6:32,659,467...32,666,657
Ensembl chr 6:32,659,467...32,668,383
G
HLA-DRB1
major histocompatibility complex, class II, DR beta 1
susceptibility
IAGP
DNA:polymorphism:cds:HLA-DRB1*0301 (human)
RGD
PMID:11555411
RGD:5147809
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
G
HMOX1
heme oxygenase 1
treatment
ISO
RGD
PMID:24941846
RGD:10450595
NCBI chr22:35,381,096...35,394,207
Ensembl chr22:35,380,361...35,394,214
G
HNRNPH1
heterogeneous nuclear ribonucleoprotein H1
IDA
RGD
PMID:19264855
RGD:10054311
NCBI chr 5:179,614,178...179,634,784
Ensembl chr 5:179,614,178...179,634,784
G
ICAM1
intercellular adhesion molecule 1
treatment
IEP ISO
protein:increased expression:salivary gland protein:increased expression:plasma
RGD
PMID:11359451 PMID:21589878 PMID:15037117
RGD:8158122 , RGD:8547705 , RGD:8547696
NCBI chr19:10,271,120...10,286,615
Ensembl chr19:10,271,093...10,286,615
G
ID3
inhibitor of DNA binding 3
ISS
OMIM:270150
MouseDO
NCBI chr 1:23,557,926...23,559,501
Ensembl chr 1:23,557,926...23,559,501
G
IFNG
interferon gamma
ISO IEP
RGD
PMID:15584966 PMID:28421993
RGD:8142390 , RGD:14975117
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
G
IL10
interleukin 10
IAGP
RGD
PMID:12233881
RGD:1580479
NCBI chr 1:206,767,602...206,772,494
Ensembl chr 1:206,767,602...206,774,541
G
IL12A
interleukin 12A
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 3:159,988,835...159,996,019
Ensembl chr 3:159,988,835...159,996,019
G
IL13
interleukin 13
IEP
protein:increased expression:serum
RGD
PMID:12051401
RGD:8549582
NCBI chr 5:132,656,522...132,661,110
Ensembl chr 5:132,656,263...132,661,110
G
IL17A
interleukin 17A
ISO
RGD
PMID:21182786
RGD:8696035
NCBI chr 6:52,186,375...52,190,638
Ensembl chr 6:52,186,375...52,190,638
G
IL18
interleukin 18
IEP
protein:increased expression:saliva
RGD
PMID:23906036
RGD:8655918
NCBI chr11:112,143,260...112,164,094
Ensembl chr11:112,143,251...112,164,096
G
IL1RN
interleukin 1 receptor antagonist
IAGP IEP
DNA:repeats:intron:IVS2+914_1000dup IL1RN*2 (human) protein:increased expression:conjunctiva (human)
RGD
PMID:9646842 PMID:11527941
RGD:8549786 , RGD:8549807
NCBI chr 2:113,099,360...113,134,014
Ensembl chr 2:113,099,315...113,134,016
G
IL2
interleukin 2
ISS
OMIM:270150
MouseDO
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
G
IL23R
interleukin 23 receptor
IEP
protein:increased expression:minor salivary gland:
RGD
PMID:22262980
RGD:8549566
NCBI chr 1:67,138,637...67,265,903
Ensembl chr 1:67,138,907...67,259,979
G
IL2RA
interleukin 2 receptor subunit alpha
ISS
OMIM:270150
MouseDO
NCBI chr10:6,010,689...6,062,367
Ensembl chr10:6,010,689...6,062,370
G
IL4
interleukin 4
ISS
OMIM:270150
MouseDO
NCBI chr 5:132,673,989...132,682,678
Ensembl chr 5:132,673,986...132,682,678
G
IL6
interleukin 6
severity
IEP IAGP
protein:increased expression:plasma: DNA:polymorphims:promoter:-174G>C(human)
RGD
PMID:11426023 PMID:11426023
RGD:7829718 , RGD:7829718
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IRAK1BP1
interleukin 1 receptor associated kinase 1 binding protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 6:78,867,551...78,979,411
Ensembl chr 6:78,867,551...78,946,440
G
ITSN2
intersectin 2
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 2:24,202,864...24,361,368
Ensembl chr 2:24,202,864...24,360,536
G
LTA
lymphotoxin alpha
no_association susceptibility
ISO IAGP IEP
DNA:SNPs: :multiple (human) DNA:SNP, haplotype:intron: (rs909253) (human) protein:increased expression:saliva, serum
RGD
PMID:20952683 PMID:22294627 PMID:22294627 PMID:20952683
RGD:8548776 , RGD:8548787 , RGD:8548787 , RGD:8548776
NCBI chr 6:31,560,610...31,574,324
Ensembl chr 6:31,572,054...31,574,324
G
MAP3K14
mitogen-activated protein kinase kinase kinase 14
ISS
OMIM:270150
MouseDO
NCBI chr17:45,263,119...45,317,020
Ensembl chr17:45,263,119...45,317,029
G
MMP3
matrix metallopeptidase 3
IEP
RGD
PMID:19332626
RGD:8693671
NCBI chr11:102,835,801...102,843,609
Ensembl chr11:102,835,801...102,843,609
G
MMP9
matrix metallopeptidase 9
IEP IDA
protein:increased activity:saliva
RGD
PMID:15316122 PMID:9923658
RGD:8547814 , RGD:8547858
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
G
MUC16
mucin 16, cell surface associated
IEP
mRNA, protein:increased expression:conjunctival epithelial cell, tear
RGD
PMID:19122828
RGD:7364772
NCBI chr19:8,848,844...9,065,751
Ensembl chr19:8,848,844...9,010,390
G
MUC19
mucin 19, oligomeric (gene/pseudogene)
IEP ISS
mRNA:decreased expression:conjunctival epithelial cell OMIM:270150
MouseDO RGD
PMID:18184611
RGD:7364736
NCBI chr12:40,393,394...40,570,757
Ensembl chr12:40,393,395...40,570,832
G
MUC5AC
mucin 5AC, oligomeric mucus/gel-forming
IEP
mRNA:decreased expression:conjunctival epithelial cell
RGD
PMID:18184611
RGD:7364736
NCBI chr11:1,157,953...1,201,138
Ensembl chr11:1,157,953...1,201,138
G
NCF1
neutrophil cytosolic factor 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:28135245
NCBI chr 7:74,774,011...74,789,315
Ensembl chr 7:74,774,011...74,789,315
G
NEFL
neurofilament light chain
IEP
protein:increased expression:CSF (human)
RGD
PMID:32423153
RGD:127284890
NCBI chr 8:24,950,955...24,956,612
Ensembl chr 8:24,950,955...24,956,721
G
NFKBIA
NFKB inhibitor alpha
ISS ISO
OMIM:270150
MouseDO RGD
PMID:20696914
RGD:126908016
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
PHIP
pleckstrin homology domain interacting protein
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 6:78,934,419...79,078,254
Ensembl chr 6:78,934,419...79,078,287
G
PON1
paraoxonase 1
IEP
protein:decreased activity:serum (human)
RGD
PMID:20497955
RGD:8547550
NCBI chr 7:95,297,676...95,324,532
Ensembl chr 7:95,297,676...95,324,532
G
PRDM1
PR/SET domain 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 6:105,992,690...106,109,938
Ensembl chr 6:105,993,463...106,109,939
G
PTPN22
protein tyrosine phosphatase non-receptor type 22
no_association
IAGP
DNA:snp:cds:c.1858C>T (human)
RGD
PMID:16163373 PMID:15933742
RGD:11534998 , RGD:11534999
NCBI chr 1:113,813,811...113,871,759
Ensembl chr 1:113,813,811...113,871,753
G
PTTG1
PTTG1 regulator of sister chromatid separation, securin
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 5:160,421,855...160,428,744
Ensembl chr 5:160,421,855...160,428,739
G
REG1A
regenerating family member 1 alpha
IEP
protein:increased expression:minor salivary gland, salivary ductal epithelium (human)
RGD
PMID:19016805
RGD:9850137
NCBI chr 2:79,120,488...79,123,409
Ensembl chr 2:79,120,362...79,123,409
G
RORC
RAR related orphan receptor C
ISS
OMIM:270150
MouseDO
NCBI chr 1:151,806,071...151,831,802
Ensembl chr 1:151,806,071...151,831,845
G
SATB1
SATB homeobox 1
ISS
OMIM:270150
MouseDO
NCBI chr 3:18,345,377...18,445,592
Ensembl chr 3:18,345,377...18,445,621
G
SELP
selectin P
IEP
protein:increased expression:plasma
RGD
PMID:19832990
RGD:6478702
NCBI chr 1:169,588,849...169,630,124
Ensembl chr 1:169,588,849...169,630,193
G
ST14
ST14 transmembrane serine protease matriptase
ISS
OMIM:270150
MouseDO
NCBI chr11:130,159,782...130,210,362
Ensembl chr11:130,159,782...130,210,362
G
STAT4
signal transducer and activator of transcription 4
susceptibility no_association
IAGP EXP
DNA:SNP:intron: (rs7582694) (human) CTD Direct Evidence: marker/mechanism DNA:SNP:intron: (rs7574865) (human)
CTD RGD
PMID:24097066 PMID:24097067 PMID:20535138 PMID:20360187 PMID:18273036
RGD:8661690 , RGD:8661709 , RGD:8661708
NCBI chr 2:191,029,576...191,151,596
Ensembl chr 2:191,029,576...191,178,435
G
TGFB1
transforming growth factor beta 1
severity
ISO ISS
OMIM:270150
MouseDO RGD
PMID:9358754 PMID:7554451
RGD:7394829 , RGD:7394845
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
G
THBS1
thrombospondin 1
ISS
OMIM:270150
MouseDO
NCBI chr15:39,581,079...39,599,466
Ensembl chr15:39,581,079...39,599,466
G
TNF
tumor necrosis factor
treatment
IAGP ISO
DNA:polymorphism: :-1031T>C(human)
RGD
PMID:22703762 PMID:24941846
RGD:7394766 , RGD:10450595
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TNFAIP3
TNF alpha induced protein 3
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097066 PMID:24097067
NCBI chr 6:137,866,349...137,883,312
Ensembl chr 6:137,867,214...137,883,314
G
TNFSF13B
TNF superfamily member 13b
ISS
OMIM:270150
MouseDO
NCBI chr13:108,269,629...108,308,484
Ensembl chr13:108,251,240...108,308,484
G
TNIP1
TNFAIP3 interacting protein 1
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:24097067
NCBI chr 5:151,029,943...151,087,685
Ensembl chr 5:151,029,945...151,093,577
G
TRAF3IP2
TRAF3 interacting protein 2
ISS
OMIM:270150
MouseDO
NCBI chr 6:111,555,381...111,605,878
Ensembl chr 6:111,555,381...111,606,906
G
VIM
vimentin
IDA
RGD
PMID:6352937
RGD:6480477
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
G
VIP
vasoactive intestinal peptide
ISO
RGD
PMID:22059987
RGD:5685375
NCBI chr 6:152,750,797...152,759,760
Ensembl chr 6:152,750,797...152,759,765
G
GSTM1
glutathione S-transferase mu 1
susceptibility
IAGP
DNA:deletion: :
RGD
PMID:10616008
RGD:5491001
NCBI chr 1:109,687,817...109,693,745
Ensembl chr 1:109,687,814...109,709,039
G
IDO1
indoleamine 2,3-dioxygenase 1
ISO
RGD
PMID:26914138
RGD:11529541
NCBI chr 8:39,913,891...39,928,790
Ensembl chr 8:39,902,275...39,928,790
G
IL6
interleukin 6
susceptibility
EXP IAGP
CTD Direct Evidence: marker/mechanism
CTD OMIM
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
G
IL6R
interleukin 6 receptor
treatment
IMP
RGD
PMID:18358927
RGD:10402823
NCBI chr 1:154,405,343...154,469,450
Ensembl chr 1:154,405,193...154,469,450
G
MIF
macrophage migration inhibitory factor
susceptibility
IAGP EXP
CTD Direct Evidence: marker/mechanism
OMIM CTD
NCBI chr22:23,894,383...23,895,223
Ensembl chr22:23,894,383...23,895,227
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all